-
SpringWorks names a CEO, inks a combo therapy deal with BeiGene
fiercebiotech
September 07, 2018
SpringWorks came to life with a clutch of drugs licensed from Pfizer, but won't rely on Pfizer’s shelves forever, with plans to boost its pipeline by partnering with other biopharmas and academic institutions.
-
New cancer treatment uses enzymes to boost immune system and fight back
worldpharmanews
August 29, 2018
Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
-
GIC receives govt funding for immuno-oncology project
biospectrumasia
August 23, 2018
The company is currently conducting studies on a family of compounds targeted towards the Adenosine 2a receptor.
-
Researchers develop predictor for immunotherapy response in melanoma
biospectrumasia
August 22, 2018
The predictor was developed by Noam Auslander, Ph.D., with other researchers in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI)...
-
NUS researchers uncover a bidirectional regulator in cancer cells
biospectrumasia
August 21, 2018
The patent addresses Cellect's devices and methods for specifically selecting desired stem cells from a heterogeneous cell population for use in a range of medical indications.
-
Scientists develop platform to kill cancer cells
biospectrumasia
August 20, 2018
This manmade nanohybrid has been tested both in vitro and in vivo.
-
China Pharmaceutical Industry Rankings Released: The Top 10 Unchanged
Muzi
August 17, 2018
The list of top 100 pharmaceutical industry enterprises of previous year would be released in the China Pharmaceutical Industry Information Annual Conference hosted by China National Pharmaceutical Industry Center, and this year is no exception.
-
PHE data shows link between cancer diagnosis route and treatment
pharmatimes
August 17, 2018
Public Health England (PHE) has revealed new data showing that the way that cancer patients are diagnosed can affect their treatment options.
-
Most Postmenopausal Bleeding Not Associated With Cancer
drugs
August 15, 2018
Most women with postmenopausal bleeding (PMB) will not be diagnosed with endometrial cancer, according to a review published online Aug. 6 in JAMA Internal Medicine.
-
Jury Awards $289 Million in Case Linking Roundup to Man's Cancer
drugs
August 14, 2018
A $289 million award against Monsanto in a case linking its Roundup week killer to terminal cancer in a former school groundskeeper may lead to similar judgments against the company, according to the man's lawyers.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
